MassMutual Private Wealth & Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Buy	3,853 +494	+15%	+$1.65K	﹤0.01%	1249
2026 Q1	$10.3K	Sell	3,359 -31	-0.9%	-$120	﹤0.01%	1356
2025 Q4	$13.9K	Sell	3,390 -146	-4%	-$723	﹤0.01%	1261
2025 Q3	$17.3K	Buy	3,536 +436	+14%	+$2.29K	﹤0.01%	1180
2025 Q2	$15.7K	Buy	3,100 +600	+24%	+$2.95K	﹤0.01%	1203
2025 Q1	$13.2K	Buy	2,500 +400	+19%	+$2.92K	﹤0.01%	1191
2024 Q4	$14.2K	Hold	2,100	–	–	﹤0.01%	1126
2024 Q3	$13.8K	Hold	2,100	–	–	﹤0.01%	1026
2024 Q2	$15.8K	Buy	+2,100	New	+$18.3K	﹤0.01%	927

Other funds holding RXRX

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AWM

Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return

NWMG

National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

MassMutual Private Wealth & Trust's RXRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Recursion Pharmaceuticals (RXRX) stake by 15% in Q2 2026, buying an estimated $1.65K and bringing the position to 3,853 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

MassMutual Private Wealth & Trust first reported a position in RXRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.3K in Q3 2025. 28 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

MassMutual Private Wealth & Trust held 3,853 shares of Recursion Pharmaceuticals worth $14.1K as of Q2 2026.
MassMutual Private Wealth & Trust bought 494 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.65K.
Recursion Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1249 holding.
MassMutual Private Wealth & Trust first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
MassMutual Private Wealth & Trust's Recursion Pharmaceuticals position peaked at $17.3K in Q3 2025.
28 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.